Table 3 Summary table
Variable | Treatment | |
|---|---|---|
Group A | Group B | |
(N = 45) | (N = 136) | |
Age | 53.3 ± 15.1 | 51.8 ± 14.9 |
IPSS | ||
Baseline value | 21.6 ± 7.2 | 18.3 ± 6.4 |
Value at visit 2 | 23.7 ± 6.1 | 23.1 ± 5.7 |
Change from baseline | 2.1 ± 7.9 | 4.7 ± 7.9 |
Test of change from baseline | P = 0.0767 | P < .0001 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.0593 | |
Voiding frequency (n/day) | ||
Baseline value | 7.7 ± 2.5 | 7.8 ± 2.1 |
Value at visit 2 | 4.2 ± 1.4 | 4.1 ± 1.9 |
Change from baseline | −3.5 ± 2.7 | −3.6 ± 2.8 |
Test of change from baseline | P < .0001 | P < .0001 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.8560 | |
Uroflowmetry (ml/s) | ||
Baseline value | 13.1 ± 6.5 | 11.6 ± 3.8 |
Value at visit 2 | 16.4 ± 6.7 | 17.2 ± 6.5 |
Change from baseline | 3.2 ± 5.3 | 5.6 ± 7.3 |
Test of change from baseline | P = 0.0002 | P < .0001 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.0638 | |
Voided volume and post voided residual PVR (ml) | ||
Baseline value | 98.7 ± 20.5 45 ± 9.7 | 112.7 ± 19.3 51 ± 9.3 |
Value at visit 2 | 137.3 ± 33.9 32.4 ± 9.9 | 139.2 ± 25.3 30.1 ± 12.0 |
Change from baseline | 38.6 ± 26.3 12.6 ± 9.1 | 26.5 ± 23.7 20.9 ± 11.4 |
Test of change from baseline | P = 0.0002 | P < .0001 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.0478 | |
Perineal pain | ||
Baseline value | 3.2 ± 1.8 | 3.8 ± 2.0 |
Value at visit 2 | 2.5 ± 1.2 | 2.4 ± 1.1 |
Change from baseline | −0.6 ± 2.2 | −1.3 ± 2.4 |
Test of change from baseline | P = 0.0699 | P < .0001 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.0787 | |
PSA | ||
Baseline value | 2.8 ± 2.3 | 3.6 ± 3.5 |
Value visit 2 | 2.9 ± 2.1 | 3.1 ± 2.4 |
Change from baseline | 0.1 ± 2.5 | −0.5 ± 3.7 |
Test of change from baseline | 0.5837 | 0.5036 |
Change vs baseline – test between two groups Two-Sample T-Test | P = 0.3613 | |